AU2002362992A1 - Methods and compositions for modulating alpha adrenergic receptor activity - Google Patents

Methods and compositions for modulating alpha adrenergic receptor activity

Info

Publication number
AU2002362992A1
AU2002362992A1 AU2002362992A AU2002362992A AU2002362992A1 AU 2002362992 A1 AU2002362992 A1 AU 2002362992A1 AU 2002362992 A AU2002362992 A AU 2002362992A AU 2002362992 A AU2002362992 A AU 2002362992A AU 2002362992 A1 AU2002362992 A1 AU 2002362992A1
Authority
AU
Australia
Prior art keywords
compositions
methods
adrenergic receptor
receptor activity
alpha adrenergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002362992A
Inventor
Ken Chow
Wenkui Ken Fang
Michael E. Garst
Daniel W. Gil
Larry A. Wheeler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of AU2002362992A1 publication Critical patent/AU2002362992A1/en
Abandoned legal-status Critical Current

Links

AU2002362992A 2001-10-19 2002-10-11 Methods and compositions for modulating alpha adrenergic receptor activity Abandoned AU2002362992A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/039,827 2001-10-19

Publications (1)

Publication Number Publication Date
AU2002362992A1 true AU2002362992A1 (en) 2003-05-06

Family

ID=

Similar Documents

Publication Publication Date Title
AU2001253384A1 (en) Methods and compositions for modulating alpha adrenergic receptor activity
EP1432431A4 (en) Methods and compositions for modulating interleukin-21 receptor activity
AU2002953533A0 (en) Fc receptor modulating compounds and compositions
AU2003276853A1 (en) Ziegler-natta catalyst and methods for making and using same
EP1539218A4 (en) Compositions and methods for modulating lymphocyte activity
AU2003251858A1 (en) Microbubble compositions, and methods for preparing and using same
AU2002315407A1 (en) Compositions and methods for modulating plant development
AU2003265681A1 (en) Indoles having anti-diabetic activity
WO2001078702A3 (en) Methods and compositions for modulating alpha adrenergic receptor activity
AU2003297908A1 (en) Articulated elements and methods for use
AU2002326948A1 (en) Piperizinones as modulators of chemokine receptor activity
WO2001078703A3 (en) Methods and compositions for modulating alpha adrenergic receptor activity
HRP20031096A2 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
AU2003220973A1 (en) Modification catalyst composition
AU2002366094A1 (en) Composition and method for modulating bar/fxr receptor activity
AU2003225379A1 (en) Mouse pad
AU2002218919A1 (en) Compositions and methods for regulating receptor clustering
AU2002306586A1 (en) Methods for modulating g2a receptor activity
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU5294700A (en) Note pad
AU2002332696A1 (en) Solid support dirhodium catalyst compositions and methods for making and using same
AU2002362992A1 (en) Methods and compositions for modulating alpha adrenergic receptor activity
AU2002331753A1 (en) Dirhodium catalyst compositions and methods for using same
AU5931300A (en) Ringene compositions and methods for use thereof
AU2002364722A1 (en) Methods and compositions for diagnosing and treating hypotrichosis simplex